Additional file 2: of A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
- Fang Zhao (11980)
- Ekaterina Olkhov-Mitsel (1975102)
- Shivani Kamdar (3423416)
- Renu Jeyapala (6005801)
- Julia Garcia (6005807)
- Rachel Hurst (227017)
- Marcelino Hanna (6005813)
- Robert Mills (6005816)
- Alexandra Tuzova (6005819)
- Eve OâReilly (6005870)
- Sarah Kelly (573743)
- Colin Cooper (239930)
- Daniel Brewer (21016)
- Antoinette Perry (6005825)
- Jeremy Clark (120973)
- Neil Fleshner (361896)
- Bharati Bapat (112041)
Publication date
November 2018
DOIAbstract
Figure S1. Diagnostic and prognostic ability of ProCUrE and age-adjusted PSA in the training cohort. Figure S2. Receiver operating characteristic curve analysis of training cohort for (A) benign vs PCa, clinically insignificant vs clinically significant PCa as determined by (B) GS, (C) CAPRA, and (D) DâAmico. (DOCX 291 kb
Add to ORKG